← All organizations

Cyclacel Pharmaceuticals, Inc.

For profitWebsite ↗

Also known as: Cyclacel Pharmaceuticals, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Mar 3, 2023

Timeline

1990s

Jun 1, 1996
Cyclacel Pharmaceuticals, Inc.— Founded

2000s

Dec 15, 2005
Xcyte Therapies— Acquired

Drugs by trial phase (12 distinct, 22 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (7 own, 1 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Xcyte Therapies

Recent trials (25)

NCT05817890Lead sponsorEarly Phase 1Mar 3, 2023
NCT05817890Study chairEarly Phase 1Mar 3, 2023
NCT05358379Lead sponsorPhase 1/Phase 2Apr 14, 2022
NCT05168904Lead sponsorPhase 1/Phase 2Oct 22, 2021
NCT04983810Lead sponsorPhase 1/Phase 2Jul 12, 2021
NCT04983810Study chairPhase 1/Phase 2Jul 12, 2021
NCT04017546Lead sponsorPhase 1Jul 17, 2019
NCT03884829Lead sponsorPhase 1Mar 25, 2019
NCT03739554Lead sponsorPhase 1Jan 25, 2019
NCT03641755CollaboratorPhase 1/Phase 2Oct 1, 2018
NCT02649751CollaboratorPhase 2Feb 1, 2016
NCT02552953Lead sponsorPhase 1Sep 1, 2015
NCT01253460CollaboratorPhase 2Jul 1, 2011
NCT01303796Lead sponsorPhase 3Jan 1, 2011
NCT01211457Lead sponsorPhase 1/Phase 2Jun 1, 2010

Details

Founded: Berkeley Heights, NJ, US Jun 1, 1996
Last known activity: Mar 3, 2023